HIGHLIGHTS
- who: Qingling Zhang and colleagues from the Post-Graduate Institute, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China have published the research: Clinical Evaluation and Exploration of Mechanisms for Modified Xiebai Powder or Modified Xiebai Powder Combined with Western Medicine in the Treatment of Pneumonia, in the Journal: Computational and Mathematical Methods in Medicine of 12/Oct/2022
- what: In this study, meta-analysis combined with network pharmacology was used to evaluate Xiebai Powder in the treatment of pneumonia systematically and to predict its potential mechanism of action.
- how: Enumeration data were analyzed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.